Everything below is organized by what clients need the science to produce, not by format, medium, or output type. If you know your challenge, find it here. If you're not sure, start a conversation.
Scientifically accurate, narratively structured animation that makes the mechanism legible to a non-scientist audience without sacrificing scientific integrity. Built from the argument backward.
Our animators are Certified Medical Illustrators or work under their supervision. The science in every frame is validated; the argument in every sequence was built by a strategist who read the data room.
Explore the capability →Medical and scientific illustration at the highest level of craft and accuracy, from single figures to complete visual systems for congress, publication, and digital.
Every figure is drawn by a Certified Medical Illustrator and checked against the current literature before it ships. Accuracy isn't a review step; it's who does the work.
See examples →The upstream work: structuring the scientific argument before any visual is designed. We build the narrative architecture for pitches, payer submissions, KOL and regulatory communication.
We read the primary data, map what each audience already believes, and engineer the argument that moves them. The words come last.
Start with a conversation →Brand strategy for upstream biotech and innovation-stage organizations whose brand must carry scientific authority. CVP development, visual identity, and messaging architecture, grounded in the science.
We're a science communication studio that develops brand strategy, not a design studio that applies brand to science. The identity is built from the mechanism outward, so it holds up in front of scientists and investors alike.
See examples →Scientific posters, investor presentations, advisory board materials, and KOL communication designed to perform in high-stakes environments. Strategy-first, scientifically accurate.
We design for the room, not the deck. Every choice answers one question: what does this audience need to believe to act, and what evidence gets them there?
See examples →Science communication for synthetic biology, deep tech, and emerging-science ventures, translating frontier science for the investors, partners, and regulators who decide whether it gets built.
Frontier science has to survive expert scrutiny and reach non-experts at the same time. We hold both: rigor for the specialist, clarity for the room that decides.
Start with a conversation →